<![CDATA[Press release - 2 Sept 2026]]>Press release - 2 Sept 2026

Teva Announces Positive Topline Results from Phase 2a Study in Celiac Disease for Its Anti-IL-15 Antibody...

https://www.tevapharm.com/news-and-media/latest-news/teva-announces-positive-topline-results-from-phase-2a-study-in-celiac-disease-for-its-anti-il-15-antibody/

TEV'408 is also in Phase 1b testing for the treatment of vitiligo.

'408

]]>https://postcall.pub/topic/2fec787e-f2a6-4578-a4b7-25e72b4c4a7f/press-release-2-sept-2026RSS for NodeThu, 08 Oct 2026 23:13:41 GMTWed, 02 Sep 2026 18:47:21 GMT60<![CDATA[Reply to Press release - 2 Sept 2026 on Wed, 02 Sep 2026 18:49:04 GMT]]>Great news - perhaps this can help those with refractory Celiac someday.

I'm wondering how they got people to volunteer for the trial, given the possibility of being placed in the placebo group.

]]>https://postcall.pub/post/https://zeroes.ca/users/Rhyothemis/statuses/117202940363138503https://postcall.pub/post/https://zeroes.ca/users/Rhyothemis/statuses/117202940363138503Wed, 02 Sep 2026 18:49:04 GMT